Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study links higher enteric disease risk to E. coli in high-risk water supplies

26

Mar 2026

Study links higher enteric disease risk to E. coli in high-risk water supplies

A nationwide New Zealand study found no significant overall link between most routine drinking water quality indicators and enteric disease risk, but E. coli signals emerged in higher-risk settings such as surface-water supplies, systems with known source-water risks, and periods of heavy rainfall. The findings suggest that sporadic bacterial enteric disease may sometimes be linked to drinking water contamination, especially in vulnerable systems, while also highlighting important limitations and the need for targeted monitoring.

GLP-1 medications show mixed effects on body contouring outcomes

26

Mar 2026

GLP-1 medications show mixed effects on body contouring outcomes

For patients undergoing body contouring surgery to remove excess abdominal skin after massive weight loss, use of GLP-1 weight-loss medications may have mixed effects on complication risks, suggests a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.